Nafcillin
NDC Package 36000-175-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nafcillin is a medication used to treat a wide variety of bacterial infections. Marketed by Claris Lifesciences, Inc., this product is identified by NDC 36000-175 and is authorized under FDA application ANDA090560.

Identification & Billing

NDC Package Code
36000-175-10
Package Description
10 VIAL in 1 PACKAGE / 1 INJECTION in 1 VIAL (36000-175-01)
Product Code
36000-175
11-Digit Billing Format
36000017510
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nafcillin
Dosage Form
-
Usage Information
This medication is used to treat a wide variety of bacterial infections. This medication is known as a penicillin-type antibiotic. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Claris Lifesciences, Inc.
FDA Application #
ANDA090560
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-01-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 36000-175-10 identifies a specific commercial package of 10 vial in 1 package / 1 injection in 1 vial (36000-175-01) of Nafcillin, labeled by Claris Lifesciences, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Claris Lifesciences, Inc. on February 01, 2012. The current certification is valid through December 31, 2017.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections. This medication is known as a penicillin-type antibiotic. It works by stopping the growth of bacteria.

How is this Claris Lifesciences, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 36000017510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
36000-175-10
11-Digit CMS (5-4-2)
36000-0175-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.